has received institutional funding for idiopathic pulmonary fibrosis research from Bristol-Myers Squibb, Genentech, Gilead Sciences, and MedImmune, and she serves on a data?monitoring committee for Boehringer Ingelheim and participated in an advisory committee for Genentech
has received institutional funding for idiopathic pulmonary fibrosis research from Bristol-Myers Squibb, Genentech, Gilead Sciences, and MedImmune, and she serves on a data?monitoring committee for Boehringer Ingelheim and participated in an advisory committee for Genentech. female)6-min walk test? 400 meven without an intense exposure. Despite universal prophylaxis, CMV infection will occur in up to one-third…